Form 4 Filing for Kimberly J. Popovits at 10x Genomics, Inc.

This filing reports a transaction by Kimberly J. Popovits, a director at 10x Genomics, Inc. On June 4, 2026, Ms. Popovits acquired 8,829 shares of Class A Common Stock through restricted stock units (RSUs) that vest quarterly. The acquisition had a price of $0.0 per share, and following this transaction, she holds 37,445 shares. The filing also includes a Power of Attorney document, authorizing Randy Wu and James Bryant to act on Ms. Popovits' behalf for SEC filings related to Section 16 of the Securities Exchange Act of 1934.